Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center

NCT07223437 is registered in ClinicalTrials.gov with University of Tennessee Graduate School of Medicine as lead sponsor.

NCT NCT07223437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07223437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REVASC-PAD: REstricted VASCular Exercise for Peripheral Arterial Disease - A Feasibility Study at University of Tennessee Medical Center
Lead sponsor
University of Tennessee Graduate School of Medicine
Phase
Not applicable
Overall status
Recruiting
Start date
April 27, 2026
Completion date
April 27, 2027
Enrollment
81 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease